These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35158844)
1. Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers. Lim AH; Chan JY; Yu MC; Wu TH; Hong JH; Ng CCY; Low ZJ; Liu W; Vikneswari R; Sung PC; Fan WL; Teh BT; Hsieh SY Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158844 [TBL] [Abstract][Full Text] [Related]
2. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Poon SL; Pang ST; McPherson JR; Yu W; Huang KK; Guan P; Weng WH; Siew EY; Liu Y; Heng HL; Chong SC; Gan A; Tay ST; Lim WK; Cutcutache I; Huang D; Ler LD; Nairismägi ML; Lee MH; Chang YH; Yu KJ; Chan-On W; Li BK; Yuan YF; Qian CN; Ng KF; Wu CF; Hsu CL; Bunte RM; Stratton MR; Futreal PA; Sung WK; Chuang CK; Ong CK; Rozen SG; Tan P; Teh BT Sci Transl Med; 2013 Aug; 5(197):197ra101. PubMed ID: 23926199 [TBL] [Abstract][Full Text] [Related]
3. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Ng AWT; Poon SL; Huang MN; Lim JQ; Boot A; Yu W; Suzuki Y; Thangaraju S; Ng CCY; Tan P; Pang ST; Huang HY; Yu MC; Lee PH; Hsieh SY; Chang AY; Teh BT; Rozen SG Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046434 [TBL] [Abstract][Full Text] [Related]
4. Mutational signature of aristolochic acid: Clue to the recognition of a global disease. Rosenquist TA; Grollman AP DNA Repair (Amst); 2016 Aug; 44():205-211. PubMed ID: 27237586 [TBL] [Abstract][Full Text] [Related]
5. Aristolochic Acid in the Etiology of Renal Cell Carcinoma. Hoang ML; Chen CH; Chen PC; Roberts NJ; Dickman KG; Yun BH; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1600-1608. PubMed ID: 27555084 [TBL] [Abstract][Full Text] [Related]
6. Mutation signatures implicate aristolochic acid in bladder cancer development. Poon SL; Huang MN; Choo Y; McPherson JR; Yu W; Heng HL; Gan A; Myint SS; Siew EY; Ler LD; Ng LG; Weng WH; Chuang CK; Yuen JS; Pang ST; Tan P; Teh BT; Rozen SG Genome Med; 2015; 7(1):38. PubMed ID: 26015808 [TBL] [Abstract][Full Text] [Related]
7. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid. Hollstein M; Moriya M; Grollman AP; Olivier M Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071 [TBL] [Abstract][Full Text] [Related]
8. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis. Meier B; Volkova NV; Gerstung M; Gartner A DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770 [TBL] [Abstract][Full Text] [Related]
9. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes. Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929 [TBL] [Abstract][Full Text] [Related]
10. Systematic Overview of Aristolochic Acids: Nephrotoxicity, Carcinogenicity, and Underlying Mechanisms. Han J; Xian Z; Zhang Y; Liu J; Liang A Front Pharmacol; 2019; 10():648. PubMed ID: 31244661 [TBL] [Abstract][Full Text] [Related]
11. Biotransformation and Toxicities of Aristolochic Acids. Sidorenko VS Adv Exp Med Biol; 2020; 1241():139-166. PubMed ID: 32383120 [TBL] [Abstract][Full Text] [Related]
12. Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid. Zhu J; Ai Q; Cheng Q; Shen D; Dong Z; Li J; Shen D; Wang W; Zhang X; Li H Front Oncol; 2022; 12():990023. PubMed ID: 36185218 [TBL] [Abstract][Full Text] [Related]
13. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. Lai MN; Wang SM; Chen PC; Chen YY; Wang JD J Natl Cancer Inst; 2010 Feb; 102(3):179-86. PubMed ID: 20026811 [TBL] [Abstract][Full Text] [Related]
14. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Arlt VM; Stiborova M; Schmeiser HH Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620 [TBL] [Abstract][Full Text] [Related]
15. Aristolochic acid-associated urothelial cancer in Taiwan. Chen CH; Dickman KG; Moriya M; Zavadil J; Sidorenko VS; Edwards KL; Gnatenko DV; Wu L; Turesky RJ; Wu XR; Pu YS; Grollman AP Proc Natl Acad Sci U S A; 2012 May; 109(21):8241-6. PubMed ID: 22493262 [TBL] [Abstract][Full Text] [Related]
16. Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy Denkert C; Untch M; Benz S; Schneeweiss A; Weber KE; Schmatloch S; Jackisch C; Sinn HP; Golovato J; Karn T; Marmé F; Link T; Budczies J; Nekljudova V; Schmitt WD; Stickeler E; Müller V; Jank P; Parulkar R; Heinmöller E; Sanborn JZ; Schem C; Sinn BV; Soon-Shiong P; van Mackelenbergh M; Fasching PA; Rabizadeh S; Loibl S Ann Oncol; 2021 Apr; 32(4):500-511. PubMed ID: 33418062 [TBL] [Abstract][Full Text] [Related]
17. DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer. Stiborová M; Arlt VM; Schmeiser HH Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036902 [TBL] [Abstract][Full Text] [Related]
18. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease. Grollman AP Environ Mol Mutagen; 2013 Jan; 54(1):1-7. PubMed ID: 23238808 [TBL] [Abstract][Full Text] [Related]
19. Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid. Jelaković B; Dika Ž; Arlt VM; Stiborova M; Pavlović NM; Nikolić J; Colet JM; Vanherweghem JL; Nortier JL Semin Nephrol; 2019 May; 39(3):284-296. PubMed ID: 31054628 [TBL] [Abstract][Full Text] [Related]
20. Aristolochic acid and its effect on different cancers in uro-oncology. Rebhan K; Ertl IE; Shariat SF; Grollman AP; Rosenquist T Curr Opin Urol; 2020 Sep; 30(5):689-695. PubMed ID: 32701724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]